realSENSe provides personalized treatment options using PCR-based diagnostic methods to identify infection-causing pathogens. Our proprietary Antimicrobial Susceptibility Test (AST) generates an effective antibiotic solution to treat the underlying infection.
Urine culture has been the gold standard for diagnosing Urinary Tract Infections (UTI) since the 1950s. Recently, however, molecular diagnostic approaches using DNA amplification techniques have started to replace outdated techniques such as urine culture. Source
The use of Effective Antimicrobial Susceptibility Testing (AST) has reduced instances of patients developing antibiotic resistance by decreasing the rate at which antibiotics are unnecessarily prescribed. AST improves the treatment process by indicating the antibiotic that the patient is resistant to, so as to not prescribe ineffective treatment methods. Source
When patients need solutions fast, clinicians trust the diagnostic precision and personalized Antimicrobial Susceptibility Testing (AST) of realSENSe. It is the ultimate solution for clinicians with patients suffering from Urinary Tract Infections (UTIs), cystitis, prostatitis, or other types of infections associated with bacteria in the Urinary Tract (UT). Our robust test identifies 30 gram-positive, gram-negative, viral, and fungi organisms and uses an automated microdilution testing methodology to generate personalized treatment plans for every patient within 24-48 hours.
Negative test results are available within 24 hours and positive results are available within 48 hours complete with antibiotic recommendations.
realSENSe can identify up to 30 pathogens and precise bacterial count using real-time PCR DNA analysis.
Strategically customized for UTIs using automated microdilution testing to determine antibiotic effectiveness.
realSENSe accurately diagnoses and reports a definitive treatment recommendation for each individual patient.
The human microbiome is composed of complex and dynamic microbial communities. It is more likely that the community characteristics, such as composition and metagenomic functionality are responsible for disease development as opposed to single organisms, thus, proving urine culture to be an extremely ineffective method of diagnosis. Over the past decade, the study of the human microbiome and its relation to health and disease has flourished due to the technological advances of microbiology testing. Source
Most PCR-based diagnostic efforts focus heavily on defining optimal uropathogen colony counts to diagnose UTIs. Meanwhile, very minimal diagnostic efforts are devoted to identifying a specific antibiotic treatment to eradicate the infection. Source
67% of uropathogens are missed with standard urine culture and 50% are missed in patients with severe urinary symptoms. Source
UTIs are some of the most common bacterial infections, affecting 150 million people each year worldwide. Source
Studies have shown that depending on the population, up to 80% of urine cultures are negative, underlining the need for more effective methods of diagnosis. Source
